Hot Reads: Dow Breaks 30,000

November 25, 2020

Compiled by ETF.com Staff

 

Dow Tops 30,000 For First Time (CNN Business)
Catalysts: Presidential transition is finally underway and more promising COVID vaccine developments.

 

Yellen Faces Another Daunting Crisis (Associated Press)
Janet Yellen was selected to lead the Treasury, but she will inherit an economy dependent on producing an aid package.

 

Why Cap Weighting Dominates (Evidence-Based Investor)
Despite all the possible index construction permutations, one type of index holds sway.

 

Russell 2000 On Track For Its Best Month Ever (CNBC)
The Russell 2000 hit another record high on Tuesday and is up more than 20% in November.

 

Vaccines, Emotions & Investment Decisions (Behavioural Investment)
Forgetting the risks that vaccines have removed means we are prone to understate their worth and give more weight to the other issues and concerns held about them.

 

'Crisis Alpha' Is Tricky To Define (Disciplined Systematic Global Macro Views) 
There are fundamental issues with the definition of this concept related to trend-following strategies that generate a mixed message for potential investors. 

 

Robo Advisors: Best & Worst Returns Over 4 Years (Financial Planning)
As the automated advice market matures, It’s clear not all robo advisors are created equal.

  

Knowledge Mining In The Market’s Past Returns (Validea) 
It can be instructive to look back, under the hood, at the drivers of past returns so that we can think about what might happen going forward.

 

Beta Can Be A Useful Risk Metric (Capital Spectator) 
But only if you use it correctly. 

 

Write A Prescription For This Pharma ETF (Benzinga)
Pharma ETFs, including “PPH,” are finally perking amid a spate of encouraging news on COVID vaccine progress.

 

Find your next ETF

Reset All